High Rates of Adherence to Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir and Ribavirin in Patients With Cirrhosis: Data From the Turquoise-II Study

被引：0
|
作者：
Pol, Stanislas
Andreone, Pietro
Lee, Samuel
Bourliere, Marc
Bourgeois, Stefan
Tang, Yuanyuan
Trinh, Roger
Martinez-Tristani, Marisol
Pockros, Paul J.
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1019
引用
收藏
页码：S1086 / S1086
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of Ombitasvir/Paritaprevir/Ritonavir+ Dasabuvir and Ribavirin in patients with compensated HCV cirrhosis
    Crisu, Georgiana C.
    Ionita-Radu, Florentina
    Costache, Raluca S.
    Balaban, Vasile D.
    Nuta, Petrut
    Stoica, Victor
    Vutcan, L. Oana
    Stefan, Ion
    Naftanaila, Florica Mali
    Jinga, Mariana
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2019, 122 (01) : 22 - 26
  • [2] Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease
    Bernstein, David E.
    Tran, Albert
    Martin, Paul
    Kowdley, Kris V.
    Bourliere, Marc
    Sulkowski, Mark S.
    Pockros, Paul J.
    Renjifo, Boris
    Wang, Deli
    Shuster, Diana L.
    Cohen, Daniel E.
    Jacobson, Ira M.
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (02): : 245 - 256
  • [3] Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
    Krastev, Zahariy
    Jelev, Deian
    Antonov, Krasimir
    Petkova, Tanya
    Atanasova, Evelina
    Zheleva, Nadezhda
    Tomov, Bojidar
    Boyanova, Yana
    Mateva, Lyudmila
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (08) : 2630 - 2635
  • [4] Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
    Feld, Jordan J.
    Bernstein, David E.
    Younes, Ziad
    Van Vlierberghe, Hans
    Larsen, Lois
    Tatsch, Fernando
    Ferenci, Peter
    LIVER INTERNATIONAL, 2018, 38 (09) : 1571 - 1575
  • [5] Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
    Zahariy Krastev
    Deian Jelev
    Krasimir Antonov
    Tanya Petkova
    Evelina Atanasova
    Nadezhda Zheleva
    Bojidar Tomov
    Yana Boyanova
    Lyudmila Mateva
    World Journal of Gastroenterology, 2016, (08) : 2630 - 2635
  • [6] Ombitasvir/paritaprevir/ritonavir + dasabuvir +/-ribavirin in real world hepatitis C patients
    Nicole Loo
    Eric Lawitz
    Naim Alkhouri
    Jennifer Wells
    Carmen Landaverde
    Angie Coste
    Rossalynn Salcido
    Michael Scott
    Fred Poordad
    World Journal of Gastroenterology, 2019, (18) : 2229 - 2239
  • [7] HCV cirrhosis at the edge of decompensation: Will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?
    Asselah, Tarik
    Bruno, Savino
    Craxi, Antonio
    JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1430 - 1433
  • [8] REAL LIFE EXPERIENCE WITH OMBITASVIR/PARITAPREVIR/RITONAVIR plus DASABUVIR AND RIBAVIRIN REGIMEN IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS
    Jinga, Mariana
    Balaban, Vasile Daniel
    Ionita-Radu, Florentina
    Costache, Raluca
    Nuta, Petrut
    Bucurica, Sandica
    Popescu, Andrada
    Stoica, Victor
    Vutcanu, Oana
    Milicescu, Mihaela
    Stefan, Ion
    Macadon, Bogdan
    Farcas, Alice
    Naftanaila, Florica
    Alexandru, Aurelia
    Robu, Georgiana C.
    GASTROENTEROLOGY, 2017, 152 (05) : S1148 - S1148
  • [9] Efficacy, Change in MELD Score, and Safety by Baseline MELD Score in Patients With Compensated Cirrhosis Receiving Ombitasvir/Paritaprevir/r and Dasabuvir Plus Ribavirin in the Phase 3 TURQUOISE-II Trial
    Jacobson, Ira M.
    Welzel, Tania M.
    Vargas, Hugo E.
    Pedrosa, Marcos C.
    Terrault, Norah
    Dieterich, Douglas
    Gordon, Fredric D.
    Kowdley, Kris V.
    Neff, Guy
    Liu, Ran
    Lopez-Talavera, Juan-Carlos
    Zeuzem, Stefan
    HEPATOLOGY, 2015, 62 : 754A - 754A
  • [10] Safety assessment in Child A cirrhotic patients treated with Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin
    Manea, E. D.
    Stefan, I
    Olariu, C.
    Calina, O. C.
    Jipa, R. E.
    Hristea, A.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (01) : 9 - 13
12345